First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug

by Teneggi, V, Novotny-Diermayr, V, Lee, LH, Yasin, M, Yeo, P, Ethirajulu, K, Gan, SBH, Blanchard, SE, Nellore, R, Umrani, DN, Gomeni, R, Teck, DLW, Li, G, Lu, QS, Cao, Y, Matter, A
Published 2021

Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

by Skibinski D.A.G., Hanson B.J., Lin Y., von Messling V., Jegerlehner A., Tee J.B.S., Chye D.H., Wong S.K.K., Ng A.A.P., Lee H.Y., Au B., Lee B.T.K., Santoso L., Poidinger M., Fairhurst A.-M., Matter A., Bachmann M.F., Saudan P., Connolly J.E.
Published 2019

Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine

by Skibinski, D.A.G, Jones, L.A, Zhu, Y.O, Xue, L.W, Au, B, Lee, B, Naim, A.N.M, Lee, A, Kaliaperumal, N, Low, J.G.H, Lee, L.S, Poidinger, M, Saudan, P, Bachmann, M, Ooi, E.E, Hanson, B.J, Novotny-Diermayr, V, Matter, A, Fairhurst, A.-M, Hibberd, M.L, Connolly, J.E
Published 2020